Quality of life in patients with multiple endocrine neoplasia type 1 (MEN1)

Springer Science and Business Media LLC - Tập 2 - Trang 27-33 - 2003
G. Berglund1, A. Lidén1, M. G. Hansson1, K. Öberg1, P. O. Sjöden2, K. Nordin2
1Department of Public Health and Caring Sciences, Department of Bioethics, Uppsala University, Uppsala, Sweden
2Department of Endocrinology, University Hospital, Uppsala, Sweden

Tóm tắt

To study quality of life among patients living with a hereditary tumor syndrome, the small group with multiple endocrine neoplasia type 1 (MEN1) was selected. It is characterized by multifocal adenomas of the pancreas, parathyroid, anterior pituitary and other endocrine glands. Patients were assessed at an in-hospital stay and six months later at home. Patients at a specialist ward for MEN1 were recruited consecutively (n = 36) during one year. Eighty-one percent participated (n = 29). Four questionnaires were used: the Hospital Anxiety and Depression Scale (HADS), the Impact of Event Scale (IES), the Life Orientation Test (LOT) and the Short Form-36 (SF-36). Psychosocial outcome measures (anxiety, depression, intrusion, avoidance) changed only marginally between the in hospital stay and six months later at home. However, depression increased for patients categorized as having a high burden of disease and treatment. Compared to population-based norm values, the SF-36 scores of the patient group MEN1were lower for General Health and Social Functioning. Optimism assessed at the hospital was a predictor of Mental Health six months later. Most MEN 1 patients (70%) were pessimists. Patients having a higher burden of disease and treatment are in need of support after discharge. Patients could easily be monitored with questionnaires and, when indicated, offered help for their psychosocial distress.

Từ khóa


Tài liệu tham khảo

Karges W, Schaaf L, Dralle H, Boehm B. Concepts for screening and diagnostic follow-up in multiple endocrine neoplasia type 1 (MEN1). Exp Clin Endocrinol Diabetes 2000; 108: 334–40.

Komminoth P, Heitz P, Klöppel G. Pathology of MEN-1: morphology, clinopathology, correlations and tumour development. J Intern Med 1998; 243: 455–64.

Schussheim D, Skarulis M, Agarwal S et al. Multiple endocrine neoplasia type 1: new clinical and basic findings. Trends Endocronol Metab 2001; 12: 173–8.

Larsson C, Skogseid B, Oeberg K et al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988; 332: 85–7.

Skogseid B. Multipel endokrin neoplasi typ 1. Uppsala: Sektionen för Onkologisk Endokronologi, 1995: 1–5.

Van’t Spijker A, Trishburg R, Duivenvoorden H. Psychological sequelae of cancer diagnosis: a meta-analytical review of 58 studies after 1980. Psychosom Med 1997; 59: 280–93.

Zabora J, BrintzenhofeSzoc K, Curbow B et al. The prevalence of psychological distress by cancer site. Psychoncology 2001; 10: 19–28.

Shaw C, Abrams K, Marteau T. Psychological impact of predicting individuals’ risks of illness: a systematic review. Soc Sci Med 1999; 49: 1571–98.

Thewes B, Meiser B, Hickie I. Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer. Psychooncology 2001; 10: 459–68.

Ell K, Nishimoto R, Morvay T et al. A longitudinal analysis of psychological adaptation among survivors of cancer. Cancer 1989; 63: 406–13.

Ellman R, Thomas B. Is psychological wellbeing impaired in long term survivors of breast cancer? J Med Screening 1995; 2: 5–9.

Ware J. SF-36 health survey update. Spine 2000; 25: 3130–9.

Kosinski M, Keller S, Ware J et al. The SF 36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis:relevant validity of scales in relation to clinical measures and arthritis severity. Med Care 1999; 37: MS23–39.

Larsson G, Sjoden P-O, Oberg K, von-Essen L. importancesatisfaction discrepancies are associated with health-related quality of life in five-year survivors of endocrine gastrointestinal tumours. Ann Oncol 1999; 10: 1321–7.

Scheier MF, Carver CS. Optimism, coping, and health: assessment and implications of generalized outcome expectancies. Health Psychol 1985; 4: 219–47.

Beckie T, Beckstead J, Webb M. Modeling women’ quality of life after cardiac events. West J Nurs Res 2001; 23: 179–94.

Allison P, Guichard C, Gilian L. A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients. Qual Life Res 2000; 9: 951–60.

Achat H, Kawachi I, Spiro A et al. Optimism and depression as predictors of physical and menatl health functioning: the normative aging study. Ann Behav Med 2000; 22: 127–30.

Hurtig M. MEN1 Clinic, Akademiska Sjukhuset Uppsala, personal communication, 2001.

Zigmond A, Snaith R. The Hospital Anxiety and Depression Scale. Acta Psych Scand 1983; 67: 361–70.

Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000; 48: 579–84.

Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosoma Res 1997; 42: 17–41.

Sharpe P, Hickey T, Wolf F. Adaptation of a general optimism scale for use with older women. Psychol Rep 1994; 74: 931–7.

Mroczek D, Spiro A 3rd, Aldwin C et al. Construct validation of optimism and pessimism in older men: findings from the normative aging study. Health Psychol 1993; 12: 406–9.

Smith T, Pope M, Rhodewalt F, Poulton J. Optimism, neuroticism, coping, and symptom reports: an alternative interpretation of the Life Orientation Test. J Pers Soc Psychol 1989; 56: 640–8.

Andersson G. The benefits of optimism, a meta-analytic review of the life orientation test. Person Ind Diff 1996; 2: 719–25.

Ware J, Shebourne D. The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection. Med Care 1992; 30: 473–83.

Sullivan M, Karlsson J, Ware J. The Swedish SF-36 health survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in sweden. Soc Sci Med 1995; 41: 1349–58.

Sullivan M, Ware J. Hälsoenkät: Svensk manual och tolkningsguide. [SF-36 Health Survey. Swedish manual and interpretation guide.] Göteborg: Sahlgrenska University Hospital, 1994.

Hjermstad M, Fayers P, Bjordal K, Kaasa S. Forming reference data on quality of life-the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 1998; 34: 1381–9.

Howell DC. Statistical Methods for Psychology. third ed. Belmont, California: Duxbury Press, 1992.

Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989.

Massie M, Popkin M. Depressive disorders. In: Holland JC, Rowland JH, editors. Handbook of Psycho-Oncology. New York: Oxford University Press, 1989.

Nordin K, Berglund G, Glimelius B, Sjödén P-O. Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer 2001; 37: 376–84.

Nordin K. Psychological Responses to Gastrointestinal Cancer. Uppsala: Uppsala Universitet, Universitetstryckeriet, 1998.

Cordova M, Andrykowski M, Kenady D et al. Frequency and correlates of posttraumatic-stress-disorder like symptoms oafter treatment for breast cancer. J Consult Clin Psychol 1995; 63: 981–6.

Walker B, Nail L, Larsen L et al. Concerns, affect, and cognitive disruption following completion of radiation treatment for localized breast or prostate cancer. Oncol Nurs Forum 1996; 23: 1181–7.

Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom Med 1979; 41: 209–13.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 2

27-33

Thông tin tác giả